BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31773012)

  • 1. Proton Beam Therapy for Bronchogenic Adenoid Cystic Carcinoma: Dosimetry, Toxicities, and Outcomes.
    Verma V; Lin L; Simone CB
    Int J Part Ther; 2018; 4(4):1-9. PubMed ID: 31773012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
    Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy and concurrent chemotherapy for esophageal cancer.
    Lin SH; Komaki R; Liao Z; Wei C; Myles B; Guo X; Palmer M; Mohan R; Swisher SG; Hofstetter WL; Ajani JA; Cox JD
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e345-51. PubMed ID: 22417808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proton beam therapy with concurrent chemotherapy for non-small cell lung cancer -- our experiences and future direction].
    Niho S; Motegi A; Akimoto T
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):144-7. PubMed ID: 25743132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
    Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton Beam Radiotherapy and Concurrent Chemotherapy for Unresectable Stage III Non-Small Cell Lung Cancer: Final Results of a Phase 2 Study.
    Chang JY; Verma V; Li M; Zhang W; Komaki R; Lu C; Allen PK; Liao Z; Welsh J; Lin SH; Gomez D; Jeter M; O'Reilly M; Zhu RX; Zhang X; Li H; Mohan R; Heymach JV; Vaporciyan AA; Hahn S; Cox JD
    JAMA Oncol; 2017 Aug; 3(8):e172032. PubMed ID: 28727865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma.
    Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T
    Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
    Takayama K; Nakamura T; Takada A; Makita C; Suzuki M; Azami Y; Kato T; Hayashi Y; Ono T; Toyomasu Y; Hareyama M; Kikuchi Y; Daimon T; Mitsudo K; Tohnai I; Fuwa N
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):659-67. PubMed ID: 26521257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative Intensity-Modulated Proton Therapy for Head and Neck Adenoid Cystic Carcinoma.
    Holliday E; Bhattasali O; Kies MS; Hanna E; Garden AS; Rosenthal DI; Morrison WH; Gunn GB; Phan J; Zhu XR; Zhang X; Frank SJ
    Int J Part Ther; 2016 Mar; 2(4):533-543. PubMed ID: 31772965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose concurrent chemo-proton therapy for Stage III NSCLC: preliminary results of a Phase II study.
    Oshiro Y; Okumura T; Kurishima K; Homma S; Mizumoto M; Ishikawa H; Onizuka M; Sakai M; Goto Y; Hizawa N; Sato Y; Sakurai H
    J Radiat Res; 2014 Sep; 55(5):959-65. PubMed ID: 24864278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Endoscopic Evaluation of Acute Radiation Esophagitis during Chemoradiotherapy with Proton Beam Therapy Boost for Esophageal Cancer.
    Hasatani K; Tamamura H; Yamamoto K; Aoyagi H; Miyanaga T; Kaizaki Y; Sawada T
    Digestion; 2020; 101(4):366-374. PubMed ID: 31067539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.
    Choi JI; Khan AJ; Powell SN; McCormick B; Lozano AJ; Del Rosario G; Mamary J; Liu H; Fox P; Gillespie E; Braunstein LZ; Mah D; Cahlon O
    Radiother Oncol; 2021 Dec; 165():142-151. PubMed ID: 34688807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
    Chhabra AM; Rice SR; Holtzman A; Choi JI; Hasan S; Press RH; Chang J; Halasz L; Tsai HK; Wang CJ; Kabolizadeh P; Gondi V; Hartsell WF; Vora SA; Vargas CE; Simone CB
    Radiother Oncol; 2023 Jun; 183():109551. PubMed ID: 36813169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial.
    Hotca A; Sindhu KK; Lehrer EJ; Hartsell WF; Vargas C; Tsai HK; Chang JH; Apisarnthanarax S; Nichols RC; Chhabra AM; Hasan S; Press RH; Lazarev S; Hajj C; Kabarriti R; Rule WG; Simone CB; Choi JI
    Adv Radiat Oncol; 2024 May; 9(5):101459. PubMed ID: 38596455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
    Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
    Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
    Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
    Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
    Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.